University of Crete (UOC)
Μελέτη των μηχανισμών δράσης των νεότερων αντιπρωτεϊνουρικών θεραπειών στη διαβητική νεφροπάθεια
Abstract
dc:descriptionINTRODUCTION.Diabetic nephropathy is the major cause of end –stage renal disease in the Western world.In diabetic nephropathy, despite the suppression of systemic renin angiotensin system (RAS), the renal RAS is activated causing detrimental effects in the kidney. Furthermore, the glomerulus and the podocytes have a central role in the pathophysiology of diabetic nephropathy.Evidence from cell culture systems link angiotensin II and increased mTOR activity. PI3K- AKT- mTOR pathway is activated and involved in the pathogenesis of diabetic nephropathy, mediating pathologic changes. The aim was to investigate the effects of losartan on the PI3K-AKT-mTOR pathway in an animal model of type 1 diabetic nephropathy, along with clinical parameters and pathologic findings.METHODS.Diabetes mellitus was induced to Sprague-Dawley rats by streptozotocin. Monthly, the animals were put in metabolic cages for 24h urine collection and measurement of albumin excretion. Five months later, daily per os administration of losartan commenced and the rats were divided in four study groups(diabetic animals, diabetic animals on losartan, healthy animals and healthy animals on losartan). Two months later, before sacrifice, the animals were housed in metabolic cages for 24h urine collection and measurement of albumin excretion. Measurements of the animals’ blood pressure also took place before they were euthanized. Glomeruli were isolated for Western blot analysis and estimation of expression of total AKT (tAKT), phosphorylated (p)/activated forms of AKT (pAKTSer473,pAKTThre308) and nephrin. Τhe glomerular and podocytic content of tAKT,pAKT308, pAKT473, mTOR and activated mTOR phosphorylated at Ser2448 (pTOR2448) was estimated by indirect immunofluorescence.Mesangial matrix expansion was evaluated and the glomerular basement membrane width was measured.RESULTS.Diabetes mellitus increased 24h urinary albumin excretion. Losartan decreased urinary albumin excretion in diabetic animals. Diabetes mellitus caused an increase in systolic blood pressure. However, losartan did not cause any effect on blood pressure of diabetic animals.As a result of diabetes, the glomerular basement membrane width increased. This effect was reversed by losartan.Mesangium was expanded in diabetic animals with losartan showing a tendency towards reduction without statistical significance.Diabetes increased glomerular pAKT308, mTOR, and pTOR2448 protein content.In losartan treated diabetic animals, glomeruli had decreased mTOR, pTOR2448, pAKT308 and pAKT473 but increased tAKT protein levels. In podocytes, diabetes mellitus caused an increase in tAKT, pAKT308, and pTOR2448. In diabetic animals, losartan administration, despite the increase in podocytic mTOR, decreased its activation as shown by decreased pTOR2448 levels. In losartan- treated healthy animals, podocytic pTOR2448 levels were increased.Immunofluorescence results were further confirmed by Western blot.CONCLUSIONS.There was a differential pattern of activation of the PI3K-AKT-mTOR pathway in glomeruli and podocytes as a result of diabetes and losartan. Losartan influences its components in a beneficial way, implying a crosstalk between the Renin Angiotensin System and the PI3K-AKT-mTOR pathway.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mavroeidi, Vassiliki
- Μαυροειδή, Βασιλική
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38651